Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Altimmune (ALT) Return on Assets (2016 - 2025)

Historic Return on Assets for Altimmune (ALT) over the last 17 years, with Q3 2025 value amounting to 0.41%.

  • Altimmune's Return on Assets rose 2300.0% to 0.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.41%, marking a year-over-year increase of 2300.0%. This contributed to the annual value of 0.54% for FY2024, which is 1200.0% down from last year.
  • Per Altimmune's latest filing, its Return on Assets stood at 0.41% for Q3 2025, which was up 2300.0% from 0.51% recorded in Q2 2025.
  • In the past 5 years, Altimmune's Return on Assets ranged from a high of 0.24% in Q1 2021 and a low of 0.66% during Q4 2024
  • For the 5-year period, Altimmune's Return on Assets averaged around 0.46%, with its median value being 0.45% (2023).
  • As far as peak fluctuations go, Altimmune's Return on Assets tumbled by -2400bps in 2022, and later surged by 2300bps in 2025.
  • Over the past 5 years, Altimmune's Return on Assets (Quarter) stood at 0.43% in 2021, then rose by 8bps to 0.39% in 2022, then dropped by -20bps to 0.47% in 2023, then plummeted by -41bps to 0.66% in 2024, then skyrocketed by 38bps to 0.41% in 2025.
  • Its last three reported values are 0.41% in Q3 2025, 0.51% for Q2 2025, and 0.61% during Q1 2025.